| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-18 |
| filingDate |
1983-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ec6b674dcb691b7f1c55a067bba741a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1dd14fbb3c1e18912a652739813be1d |
| publicationDate |
1985-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4503241-A |
| titleOfInvention |
7-Oxabicycloheptane prostaglandin intermediates |
| abstract |
7-Oxabicycloheptane prostaglandin intermediates are provided having the general structure ##STR1## wherein one of R 1 and R 2 is ##STR2## and the other is hydrogen. A method for preparing the above intermediates is also provided. The final products are used in the treatment of thrombolytic disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2530314-C1 |
| priorityDate |
1983-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |